ClinicalTrials.gov
public full text
Public Domain
Investigating NMJ Defects in SMA Following Central and Peripheral SMN Restoration
This is an observational study to investigate the improvement of NMJ defects in adult patients with SMA following treatment with Risdiplam. Eligible patients will have received treatment with daily oral Risdiplam after receiving approval through their commercial insurance or drug assistance program. All subjects will be evaluated at one visit. Eligible subjects must have been receiving risdiplam for at least 12 months.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Intrathecal Administration of scAAV9/JeT-GAN for the Treatment of Giant Axonal Neuropathy#1465914
- LAMA2-related Muscular Dystrophy Brain Study#1086342
- Extracorporeal Shock Waves Therapy (ESWT) vs Exercise in Thumb Osteoarthritis#1420364
- Postoperative Therapy After Interposition Arthroplasty in CMC1#890332
- Collagen Treatment in Facial Nerve Palsy#1408436
Record · ID 1477901
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive